Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib
Condition: Metastatic Renal Cell Carcinoma Intervention: Drug: Sunitinib Sponsors: Pfizer; International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Databases & Libraries | Kidney Cancer | Pfizer | Renal Cell Carcinoma | Research